Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

Ozempic's hidden dangers

Is Ozempic a special, life-saving medication? Or does it merely enable a new, more insidious form of fatphobia?

Salon

Ozempic, the 'miracle drug,' and the harmful idea of a future without fat

The headlines squeal with delight: Latest wonder drug will “cure” obesity.

The Conversation

The world of sugar

Dr Ulbe Bosma's book reveals sugar's societal dominance is a recent development. Refined sugar became widely available in Europe in 19th Century, but its production in Middle East and by slaves in West Indies & Brazil caused exploitation, racism, obesity & environmental destruction. In India, sugarcane, coarse & crystal sugar,…

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

Newly-identified Molecule Could Hold Key To Targeting Obesity

This novel mechanism could also help combat obesity an important risk factor for all cardiovascular diseases.

Zenger

Ötzi the Iceman may have been bald and getting fat before his murder 5,300 years ago

A new DNA analysis reveals that Ötzi the Iceman was genetically predisposed to male-pattern baldness, diabetes and obesity.

LiveScience

Virtual services recommended to tackle obesity crisis

It is hoped treating patients online will save the NHS time and money.

The Independent UK

Home economics: a recipe to beat obesity

Brief letters: Ultra-processed food | MPs’ second jobs | Criminal activity | Pothole palaver | Toilet tech

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Ro CEO charts growth past sexual health roots to obesity and beyond

Ro, the care provider formerly known as Roman, has launched a “body program."

The Independent UK

A pharma company helping Elon Musk shed weight is now worth more than the entire economy of Denmark

The weight-loss and diabetes injectables have seen a surge in demand primarily in the U.S., buoying Novo Nordisk’s profits in the first half of 2023.

Fortune

Tropical Plant Native To China Could Be Key To Beating Obesity Epidemic

Obesity is a major risk factor for several lifestyle diseases, including diabetes and high blood pressure.

Zenger

Weight-loss jabs can cut risk of heart attacks or strokes

Risk of heart attack or stroke cut by fifth, researchers say

The Independent UK

Ozempic is in the spotlight but it's just the latest in a long and strange history of weight-loss drugs

Losing weight conveniently, cheaply, safely. That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.

The Conversation

Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says

The drug “has the potential to change how obesity is regarded and treated,” the company's executive vice president for development says.

Fortune

Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests

The trial involved more than 17,600 people from across 41 countries.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Zenger

Brain’s Appetite “Control Center” Bigger In People Who Are Overweight, New Research Finds

Findings about the hypothalamus add new evidence to relevance of brain structure to weight and food consumption, researchers say.

The Independent UK

Brain’s appetite control centre different in overweight or obese people – study

The findings add further evidence to the relevance of brain structure to weight and food consumption, researchers suggest.

Kiplinger

Will Weight-Loss Drugs Spike Medicare Costs?: Kiplinger Economic Forecasts

Lawmakers are trying to get weight-loss drugs like Wegovy covered by Medicare. Long-term savings are possible, but it could cost the program $27 billion.

WEKU

Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor

Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

What the U.S. could learn from Japan about making healthy living easier

On a trip back to her parents' native country, a writer rediscovers what makes it different. The urban design, and a culture that values longevity, make good health come al lot more naturally.

Dynamite News

Study: Pecans curb obesity, reduce inflammation

Researchers found that pecans have health advantages that may lower inflammation and prevent obesity. Read further on Dynamite news:

The Conversation

When Christmas comes so do the kilos. New research tracks Australians' yo-yo weight gain

As we revel in much-cherished festive occasions and weekly get-togethers, Australians are unwittingly bearing an increasingly heavy cost – an expanding waistline.

Salon

How to best address childhood obesity

"More than 124 million children across the world are currently considered to be obese"

Fortune

Novo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether

Novo’s Ozepmic and Wegovy drugs have altered the mission of the 100-year-old Danish pharma firm best known—until now—for insulin.

The Conversation

Renaming obesity won't fix weight stigma overnight. Here's what we really need to do

The stigma that surrounds people living in larger bodies is pervasive and deeply affects the people it’s directed at. It’s been described as one of the last acceptable forms of discrimination.

The Hindu

Childhood obesity leads to a lifetime of poor health

An article on why childhood obesity is on the rise even in underdeveloped countries

1 … 48 49 50 51

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Centers for Disease Control and Prevention

222 stories

University of Cambridge

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.